https://ir.avenuetx.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/avenuetx/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.avenuetx.com/news-events/press-releases/detail/99/avenue-therapeutics-enters-into-exclusive-worldwide-license Mon, 23 Feb 26 08:00:00 -0500 https://ir.avenuetx.com/news-events/press-releases/detail/99/avenue-therapeutics-enters-into-exclusive-worldwide-license https://ir.avenuetx.com/news-events/press-releases/detail/98/avenue-therapeutics-announces-acquisition-of-subsidiary Thu, 06 Nov 25 07:00:00 -0500 https://ir.avenuetx.com/news-events/press-releases/detail/98/avenue-therapeutics-announces-acquisition-of-subsidiary https://ir.avenuetx.com/news-events/press-releases/detail/97/avenue-therapeutics-reports-third-quarter-2024-financial Thu, 14 Nov 24 16:05:00 -0500 https://ir.avenuetx.com/news-events/press-releases/detail/97/avenue-therapeutics-reports-third-quarter-2024-financial https://ir.avenuetx.com/news-events/press-releases/detail/96/avenue-therapeutics-to-participate-in-maxim-groups-2024 Wed, 09 Oct 24 08:30:00 -0400 https://ir.avenuetx.com/news-events/press-releases/detail/96/avenue-therapeutics-to-participate-in-maxim-groups-2024 https://ir.avenuetx.com/news-events/press-releases/detail/95/avenue-therapeutics-to-participate-in-upcoming-investor Tue, 03 Sep 24 08:30:00 -0400 https://ir.avenuetx.com/news-events/press-releases/detail/95/avenue-therapeutics-to-participate-in-upcoming-investor https://ir.avenuetx.com/news-events/press-releases/detail/94/avenue-therapeutics-reports-second-quarter-2024-financial Fri, 09 Aug 24 16:05:00 -0400 https://ir.avenuetx.com/news-events/press-releases/detail/94/avenue-therapeutics-reports-second-quarter-2024-financial https://ir.avenuetx.com/news-events/press-releases/detail/93/avenue-therapeutics-to-present-at-the-h-c-wainwright-5th Thu, 20 Jun 24 08:30:00 -0400 https://ir.avenuetx.com/news-events/press-releases/detail/93/avenue-therapeutics-to-present-at-the-h-c-wainwright-5th https://ir.avenuetx.com/news-events/press-releases/detail/92/avenue-therapeutics-announces-last-patient-last-visit-in Thu, 16 May 24 08:30:00 -0400 https://ir.avenuetx.com/news-events/press-releases/detail/92/avenue-therapeutics-announces-last-patient-last-visit-in https://ir.avenuetx.com/news-events/press-releases/detail/91/avenue-therapeutics-reports-first-quarter-2024-financial Wed, 15 May 24 08:30:00 -0400 https://ir.avenuetx.com/news-events/press-releases/detail/91/avenue-therapeutics-reports-first-quarter-2024-financial https://ir.avenuetx.com/news-events/press-releases/detail/90/avenue-therapeutics-announces-exercise-of-warrants-for-4-4 Mon, 29 Apr 24 08:00:00 -0400 https://ir.avenuetx.com/news-events/press-releases/detail/90/avenue-therapeutics-announces-exercise-of-warrants-for-4-4